Skip to content

Haemonetics HAE Free cash flow margin

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.3%+0.6pp
TFX
TeleflexTFX
7.9%
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
LivaNova logo
LivaNovaLIVN
11.2%-0.2pp
ICU Medical logo
ICU MedicalICUI
4.2%-1.2pp

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.37B-18.0%
Enterprise value$4.4B-12.5%
P/S2.5×-0.5×

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

Based on trailing twelve months.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's free cash flow margin?
Haemonetics (HAE) reported free cash flow margin of 19.5% in Q1 2026.
How has Haemonetics's free cash flow margin changed year-over-year?
Haemonetics's free cash flow margin increased by 86.5% year-over-year, from 10.5% to 19.5%.
What is the long-term trend for Haemonetics's free cash flow margin?
Over 3 years (2021 to 2026), Haemonetics's free cash flow margin has grown at a 19.4% compound annual growth rate (CAGR), from 11.5% to 19.5%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.